EODData

FRA, 6A3A: Autolus Therapeutics plc

06 Jul 2026
LAST:

1.370

CHANGE:
 0.00
OPEN:
1.370
HIGH:
1.370
ASK:
0.000
VOLUME:
0
CHG(%):
0.00
PREV:
1.370
LOW:
1.370
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Jul 261.3701.3701.3701.3700
03 Jul 261.3701.3701.3701.370260
02 Jul 261.3701.3701.3701.37013.6K
30 Jun 261.4301.4301.3101.4200
29 Jun 261.4101.4101.4101.4100
25 Jun 261.4001.4001.4001.4000
24 Jun 261.4401.4401.4401.4400
23 Jun 261.2601.2601.2601.2600
22 Jun 261.2901.2901.2901.2900
19 Jun 261.2901.2901.2901.2900

PROFILE

Name:Autolus Therapeutics plc
About:Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:The Mediaworks, London, United Kingdom, W12 7FP
Website:https://www.autolus.com
ISIN:US05280R1005
LEI:549300C0KZP8EYROLL02

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-1.52 
Forward P/E:-0.71 
PEG Ratio:0.08 
Price to Sales:11.73 
Price to Book:1.01 
Profit Margin:-0.13 
Operating Margin:-2.93 
Return on Assets:-0.21 
Return on Equity:-0.52 
Revenue:25.98M 
Shares:266.14M 
Market Cap:364.61M 

TECHNICAL INDICATORS

MA5:1.391.3%
MA10:1.360.6%
MA20:1.342.5%
MA50:1.370.3%
MA100:1.314.4%
MA200:1.305.2%
STO9:61.11
STO14:61.11
RSI14:53.33
WPR14:-38.89
MTM14:-0.02
ROC14:-0.01 
ATR:0.05 
Week High:1.434.4%
Week Low:1.314.6%
Month High:1.445.1%
Month Low:1.255.2%
Year High:2.2564.0%
Year Low:1.0431.7%
Volatility:46.26